In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years

Antimicrob Agents Chemother. 2008 Jun;52(6):2226-7. doi: 10.1128/AAC.00414-07. Epub 2008 Apr 7.

Abstract

Significant increases in the MIC(90)s of linezolid in multidrug-resistant Mycobacterium tuberculosis isolates were seen between the baseline period of 2001 to 2003 (0.5 microg/ml) and 2004 (2 microg/ml). The MICs were 4 microg/ml in three strains. Both fluoroquinolones (except levofloxacin) and kanamycin were found to have statistically significant degrees of concordance with linezolid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / pharmacology*
  • Antitubercular Agents / pharmacology*
  • Drug Resistance, Bacterial
  • Fluoroquinolones / pharmacology
  • Humans
  • Linezolid
  • Microbial Sensitivity Tests / standards
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / isolation & purification
  • Oxazolidinones / pharmacology*
  • Taiwan / epidemiology
  • Tuberculosis / epidemiology
  • Tuberculosis / microbiology*
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology*

Substances

  • Acetamides
  • Antitubercular Agents
  • Fluoroquinolones
  • Oxazolidinones
  • Linezolid